In last trading session, Biohaven Ltd (NYSE:BHVN) saw 1.69 million shares changing hands with its beta currently measuring 3.60. Company’s recent per share price level of $14.74 trading at $0.41 or 2.86% at ring of the bell on the day assigns it a market valuation of $1.51B. That closing price of BHVN’s stock is at a discount of -277.88% from its 52-week high price of $55.70 and is indicating a premium of 5.9% from its 52-week low price of $13.87. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.18 million shares which gives us an average trading volume of 2.18 million if we extend that period to 3-months.
For Biohaven Ltd (BHVN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.25. Splitting up the data highlights that, out of 7 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Biohaven Ltd (NYSE:BHVN) trade information
Upright in the green during last session for gaining 2.86%, in the last five days BHVN remained trading in the green while hitting it’s week-highest on Tuesday, 06/24/25 when the stock touched $14.74 price level, adding 2.9% to its value on the day. Biohaven Ltd’s shares saw a change of -57.57% in year-to-date performance and have moved 2.43% in past 5-day. Biohaven Ltd (NYSE:BHVN) showed a performance of -3.91% in past 30-days. Number of shares sold short was 10.88 million shares which calculate 4.58 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 58.5 to the stock, which implies a rise of 74.8% to its current value. Analysts have been projecting 57 as a low price target for the stock while placing it at a high target of 60. It follows that stock’s current price would drop -286.7% in reaching the projected high whereas dropping to the targeted low would mean a loss of -286.7% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -49.78% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 16.89% while estimates for its earnings growth in next 5 years are of 17.95%.
Biohaven Ltd (NYSE:BHVN)’s Major holders
Insiders are in possession of 11.96% of company’s total shares while institution are holding 90.75 percent of that, with stock having share float percentage of 103.08%. Investors also watch the number of corporate investors in a company very closely, which is 90.75% institutions for Biohaven Ltd that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at BHVN for having 7.27 million shares of worth $252.41 million. And as of 2024-06-30, it was holding 8.2855 of the company’s outstanding shares.
The second largest institutional holder is STIFEL FINANCIAL CORP, which was holding about 6.48 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.3839 of outstanding shares, having a total worth of $224.94 million.
